Lymph Node Status in the Breast Cancer Patient: Sampling Techniques and Prognostic Significance

Seminars in Roentgenology

Volumn 42, Issue 4, 2007, Pages 253-264

  Amaral, Beatriz B ^a   Meurer, Luise ^b   Whitman, Gary J ^c   Leung, Jessica W T ^d  

^a Radimagem Diagnostic Imaging   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIMONY TECHNETIUM SULFIDE TC 99M; COLLOID TC 99M; DEXTRAN; ISOSULFAN BLUE; NANOCOLLOID TC 99M; RADIOACTIVE COLLOID; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ALLERGY; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CARCINOMA IN SITU; ECHOGRAPHY; HUMAN; HUMAN TISSUE; HYPOTENSION; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MICROMETASTASIS; PATIENT SELECTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; RASH; SENTINEL LYMPH NODE BIOPSY; TECHNIQUE; TUMOR CELL; TUMOR VOLUME; URTICARIA;

BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAMMOGRAPHY; PATIENT SELECTION; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; ULTRASONOGRAPHY, MAMMARY;

EID: 34848825908     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2007.07.002     Document Type: Article

References (131)

1. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
2. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
3. Krag D.N., Weaver D.L., Alex J.C., et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-339 discussion 340
4. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398 discussion 398-401
5. Society AC: Breast Cancer Facts & Figures 2005-2006. 2005
6. Cady B., Stone M.D., Schuler J.G., et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131 (1996) 301-308
7. Tabar L., Duffy S.W., Vitak B., et al. The natural history of breast carcinoma: what have we learned from screening?. Cancer 86 (1999) 449-462
8. Rivadeneira D.E., Simmons R.M., Christos P.J., et al. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 191 (2000) 1-6 discussion 6-8
9. Ivens D., Hoe A.L., Podd T.J., et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 66 (1992) 136-138
10. Kissin M.W., Querci della Rovere G., Easton D., et al. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73 (1986) 580-584
11. Maunsell E., Brisson J., and Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36 (1993) 315-320
12. Tanis P.J., Nieweg O.E., Valdes Olmos R.A., et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 192 (2001) 399-409
13. Spratt Jr. J.S. Anatomy of the breast. Major Probl Clin Surg 5 (1967) 1-11
14. Turner-Warwick R.T. The lymphatics of the breast. Br J Surg 46 (1959) 574-582
15. Julian T.B., Krag D., Brown A., et al. Preliminary technical results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. Breast Cancer Res Treat suppl 11 (2004) (abstr 14)
16. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
17. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
18. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339 (1998) 941-946
19. Giuliano A.E., Jones R.C., Brennan M., et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 (1997) 2345-2350
20. Cox C.E., Pendas S., Cox J.M., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227 (1998) 645-651 discussion 651-643
21. McMasters K.M., Tuttle T.M., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18 (2000) 2560-2566
22. Posther K.E., Wilke L.G., and Giuliano A.E. Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping. Semin Oncol 31 (2004) 426-436
23. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
24. Kuerer H.M., and Newman L.A. Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol 23 (2005) 1698-1705
25. Noguchi M. Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat 84 (2004) 261-271
26. Cody III H.S. Sentinel lymph node biopsy for breast cancer: does anybody not need one?. Ann Surg Oncol 10 (2003) 1131-1132
27. Bedrosian I., Reynolds C., Mick R., et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88 (2000) 2540-2545
28. Chung M.H., Ye W., and Giuliano A.E. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 8 (2001) 688-692
29. Goyal A., Newcombe R.G., Chhabra A., et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat 99 (2006) 203-208
30. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
31. Specht M.C., Fey J.V., Borgen P.I., et al. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?. J Am Coll Surg 200 (2005) 10-14
32. Bleiweiss I.J. Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles. Lancet Oncol 7 (2006) 686-692
33. Tousimis E., Van Zee K.J., Fey J.V., et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 197 (2003) 529-535
34. Jin Kim H., Heerdt A.S., Cody H.S., et al. Sentinel lymph node drainage in multicentric breast cancers. Breast J 8 (2002) 356-361
35. Cody III H.S. Reoperative sentinel lymph node biopsy: Adding nuance to the management of locally recurrent breast cancer. Ann Surg Oncol (2006)
36. Taback B., Nguyen P., Hansen N., et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol 13 (2006) 1099-1104
37. Intra M., Trifiro G., Viale G., et al. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol 12 (2005) 895-899
38. Port E.R., Fey J., Gemignani M.L., et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195 (2002) 167-172
39. Haigh P.I., Hansen N.M., Qi K., et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7 (2000) 21-27
40. Wong S.L., Edwards M.J., Chao C., et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9 (2002) 272-277
41. Liberman L., and Cody III H.S. Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol 177 (2001) 887-891
42. Golshan M., Lesnikoski B.A., and Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg 72 (2006) 397-400
43. Jakub J.W., Ebert M.D., Cantor A., et al. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg 114 (2004) 1737-1742
44. Dupont E.L., Kuhn M.A., McCann C., et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180 (2000) 274-277
45. Breslin T.M., Cohen L., Sahin A., et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18 (2000) 3480-3486
46. Mamounas E.P. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 83 (2003) 931-942
47. Buchholz T.A., Hunt K.K., Whitman G.J., et al. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer 98 (2003) 1150-1160
48. Stearns V., Ewing C.A., Slack R., et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9 (2002) 235-242
49. Kell M.R., and Morrow M. Surgical aspects of inflammatory breast cancer. Breast Dis 22 (2005) 67-73
50. Sabel M.S., Schott A.F., Kleer C.G., et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 186 (2003) 102-105
51. Cody III H.S., Klauber-Demore N., Borgen P.I., et al. Is it really duct carcinoma in situ?. Ann Surg Oncol 8 (2001) 617-619
52. Intra M., Zurrida S., Maffini F., et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 10 (2003) 1160-1165
53. Intra M., Veronesi P., Mazzarol G., et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138 (2003) 309-313
54. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 (2005) 516-526
55. Gentilini O., Cremonesi M., Trifiro G., et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15 (2004) 1348-1351
56. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468 discussion 468-471
57. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
58. Cox C., White L., Allred N., et al. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13 (2006) 708-711
59. Borgstein P.J., Meijer S., and Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 349 (1997) 1668-1669
60. Pelosi E., Bello M., Giors M., et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med 45 (2004) 220-225
61. Montgomery L.L., Thorne A.C., Van Zee K.J., et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 95 (2002) 385-388 table of contents
62. King T.A., Fey J.V., Van Zee K.J., et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 11 (2004) 535-541
63. Linehan D.C., Hill A.D., Tran K.N., et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Am Coll Surg 188 (1999) 377-381
64. Goldfarb L.R., Alazraki N.P., Eshima D., et al. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid. Radiology 208 (1998) 505-509
65. Wilhelm A.J., Mijnhout G.S., and Franssen E.J. Radiopharmaceuticals in sentinel lymph-node detection-an overview. Eur J Nucl Med 26 (1999) S36-S42
66. Xavier N.L., Amaral B.B., Cerski C.T., et al. Sentinel lymph node identification and sampling in women with early breast cancer using 99m Tc labelled dextran 500 and patent blue V dye. Nucl Med Commun 22 (2001) 1109-1117
67. Mirzaei S., Rodrigues M., Hoffmann B., et al. Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. Eur J Nucl Med Mol Imaging 30 (2003) 874-878
68. Edreira M.M., Colombo L.L., Perez J.H., et al. In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun 22 (2001) 499-504
69. Aarsvold J.N., and Alazraki N.P. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 35 (2005) 116-128
70. Mariani G., Moresco L., Viale G., et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 42 (2001) 1198-1215
71. Tanis P.J., Valdes Olmos R.A., Muller S.H., et al. Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology 228 (2003) 546-551
72. Styblo T., Aarsvold J.N., Grant S.F., et al. Sentinel lymph nodes: optimizing success. Semin Roentgenol 36 (2001) 261-269
73. Liberman L., Cody III H.S., Hill A.D., et al. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer. Radiology 211 (1999) 835-844
74. Nieweg O.E., Estourgie S.H., van Rijk M.C., et al. Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol 87 (2004) 153-156
75. Noguchi M., Tsugawa K., and Miwa K. Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73 (2000) 75-80
76. Law M., Chow L.W., Kwong A., et al. Sentinel lymph node technique for breast cancer: radiation safety issues. Semin Oncol 31 (2004) 298-303
77. Nos C., Freneaux P., Guilbert S., et al. Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?. Ann Surg Oncol 8 (2001) 438-443
78. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 (2006) 4-16
79. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual. (ed 6) (2002), Springer, New York, NY 223-240
80. Khan A., Sabel M.S., Nees A., et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 12 (2005) 697-704
81. Podkrajsek M., Music M.M., Kadivec M., et al. Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15 (2005) 1044-1050
82. Bedrosian I., Bedi D., Kuerer H.M., et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patient with breast cancer. Ann Surg Oncol 10 (2003) 1025-1030
83. Rizzatto G. Towards a more sophisticated use of breast ultrasound. Eur Radiol 11 (2001) 2425-2435
84. Altinyollar H., Dingil G., and Berberoglu U. Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer. J Surg Oncol 92 (2005) 299-303
85. Whitman G.J., Sheppard D.G., Phelps M.J., et al. Breast cancer staging. Semin Roentgenol 41 (2006) 91-104
86. Feu J., Tresserra F., Fabregas R., et al. Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection. Radiology 205 (1997) 831-835
87. Luciani A., Itti E., Rahmouni A., et al. Lymph node imaging: basic principles. Eur J Radiol 58 (2006) 338-344
88. Krishnamurthy S., Sneige N., Bedi D.G., et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95 (2002) 982-988
89. Topal U., Punar S., Tasdelen I., et al. Role of ultrasound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma. Eur J Radiol 56 (2005) 382-385
90. Schwartz G.F., Giuliano A.E., and Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19 to 22, 2001. Philadelphia, Pennsylvania. Hum Pathol 33 (2002) 579-589
91. Viale G., Mastropasqua M.G., Maiorano E., et al. Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch 448 (2006) 241-247
92. Dowlatshahi K., Fan M., Anderson J.M., et al. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 8 (2001) 675-681
93. Silverberg S.G. Sentinel node processing: recommendations for pathologists. Am J Surg Pathol 26 (2002) 383-385
94. Cserni G., Amendoeira I., Apostolikas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57 (2004) 695-701
95. Cserni G. Evaluation of sentinel lymph nodes in breast cancer. Histopathology 46 (2005) 697-702
96. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55 (2002) 926-931
97. Torrenga H., Rahusen F.D., Meijer S., et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 54 (2001) 550-552
98. Viale G., Bosari S., Mazzarol G., et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85 (1999) 2433-2438
99. Viale G., Maiorano E., Mazzarol G., et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92 (2001) 1378-1384
100. Wilkinson E.J., and Hause L. Probability in lymph node sectioning. Cancer 33 (1974) 1269-1274
101. Hartveit F. The routine histological investigation of axillary lymph nodes for metastatic breast cancer. J Pathol 143 (1984) 187-191
102. Turner R.R., Giuliano A.E., Hoon D.S., et al. Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 25 (2001) 798-805
103. ADASP recommendations for processing and reporting lymph node specimens submitted for evaluation of metastatic disease. Am J Surg Pathol 25 (2001) 961-963
104. Singletary S.E., Greene F.L., and Sobin L.H. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 98 (2003) 2740-2741
105. Singletary S.E., and Connolly J.L. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 56 (2006) 37-47
106. Cserni G. Histopathologic examination of the sentinel lymph nodes. Breast J 12 (2006) S152-S156
107. Roberts C.A., Beitsch P.D., Litz C.E., et al. Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg 186 (2003) 324-329
108. Cote R.J., Peterson H.F., Chaiwun B., et al., International Breast Cancer Study Group. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 354 (1999) 896-900
109. Weinberg E.S., Dickson D., White L., et al. Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma. Am J Surg 188 (2004) 419-422
110. Fortunato L., Amini M., Farina M., et al. Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty?. Ann Surg Oncol 11 (2004) 1005-1010
111. Menes T.S., Tartter P.I., Mizrachi H., et al. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 10 (2003) 1166-1170
112. Rubio I.T., Korourian S., Cowan C., et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5 (1998) 689-694
113. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
114. Flett M.M., Going J.J., Stanton P.D., et al. Sentinel node localization in patients with breast cancer. Br J Surg 85 (1998) 991-993
115. Chao C., Wong S.L., Ackermann D., et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 182 (2001) 609-615
116. Holck S., Galatius H., Engel U., et al. False-negative frozen section of sentinel lymph node biopsy for breast cancer. Breast 13 (2004) 42-48
117. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20 (2002) 3628-3636
118. Cserni G., Sapino A., and Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 15 (2006) 347-354
119. Amin B.D., and Hoda S.A. Minimal metastatic disease in sentinel lymph nodes in breast carcinoma: some modest proposals to refine criteria for "isolated tumor cells". Adv Anat Pathol 13 (2006) 185-189
120. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 (2004) 1245-1252
121. Imoto S., Ochiai A., Okumura C., et al. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining. Eur J Surg Oncol (2006)
122. Krauth J.S., Charitansky H., Isaac S., et al. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer. Eur J Surg Oncol 32 (2006) 400-404
123. Kahn H.J., Hanna W.M., Chapman J.A., et al. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J 12 (2006) 294-301
124. Mullenix P.S., Brown T.A., Meyers M.O., et al. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am J Surg 189 (2005) 606-609 discussion 609
125. Susnik B., Frkovic-Grazio S., and Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up. Ann Surg Oncol 11 (2004) 568-572
126. Fournier K., Schiller A., Perry R.R., et al. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 239 (2004) 859-863 discussion 863-855
127. Fant J.S., Grant M.D., Knox S.M., et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10 (2003) 126-130
128. Lucignani G. Sentinel lymph node biopsy: vision, multicentre trials, professional and technological synergy. Eur J Nucl Med Mol Imaging 33 (2006) 1238-1241
129. Sanidas E.E., Daskalakis M., Sbyrakis N., et al. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol 31 (2005) 357-363
130. Maggard M.A., Lane K.E., O'Connell J.B., et al. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer?. Ann Surg Oncol 12 (2005) 41-47
131. http://www.rcseng.acuk/education/courses/new-start.html: